Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

ClinicalTrials.gov ID: NCT00428948

Public ClinicalTrials.gov record NCT00428948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.

Study identification

NCT ID
NCT00428948
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,445 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Jul 1, 2017

2007 – 2012

United States locations

U.S. sites
30
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Coastal Clinical Research Mobile Alabama 36608
University of South Alabama Mobile Alabama 36617
Apex Research of Riverside Riverside California 92503
Stanford University Medical Center Stanford California 94305-5114
University of Colorado Health Sciences Center Denver Colorado 80262
Yale University School of Medicine New Haven Connecticut 06510
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Coastal Nephrology Associates Research Center, LLC Port Charlotte Florida 33952
Emory University School of Medicine Atlanta Georgia 30308
Northwestern University Chicago Illinois 60611
University of Kansas Medical Center Kansas City Kansas 66160
Renal Associates of Baton Rough, L.L.C. Baton Rouge Louisiana 70809
John Hopkins School of Medicine Baltimore Maryland 21205
Tufts- New England Medical Center Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Mayo Medical Center Rochester Minnesota 55905
Erie County Medical Center Buffalo New York 14215
Nephrology Associates of Westchester Hawthorne New York 10532
The Rogosin Institute New York New York 10021
Columbia University Medical Center New York New York 10032
University of North Carolina, UNC, Kidney Center Chapel Hill North Carolina 27599
East Carolina University Greenville North Carolina 27834
Kidney and Hypertension Center Cincinnati Ohio 45220
University Hospitals of Cleveland/Case Cleveland Ohio 44106
Northwest Renal Clinic, Inc. Portland Oregon 97210
University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104
Charleston Nephrology Associates Charleston South Carolina 29405
Nephrology Associates, P.C. Nashville Tennessee 37205
Vanderbilt University Medical Center Nashville Tennessee 37232-1371
University of Virginia, Nephrology Clinical Research Center Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00428948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00428948 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →